Pharm Dr. Greene (Part1)

Session Overview

  • Date: January 10, 2025

  • Instructor: Patricia Greene, DMD

  • Main Focus: Reinforce key points and practical knowledge

    • Topics Covered:

      1. Drug Action and Handling (Pharmacodynamics and Pharmacokinetics)

      2. Pain Pathways

      3. Pharmacology of Local Anesthetics

    • Extra Focus: Clinical applications and relevance of these topics

Importance of Reading Material

  • Pharmacology Course/Lectures:

    • Sessions are supplementary; students must read the provided modules/nodes for thorough understanding.

    • Opportunities will be given to ask questions.

Lecture Engagement

  • Students encouraged to participate actively in the lecture.

  • Questions can be posed at any time via chat; participation is expected.

  • Breaks of 5-10 minutes planned throughout the session.

Application of Pharmacology in Dentistry

  1. Pain Management

  2. Infection Control (bacterial, viral, fungal infections)

  3. Anxiety Management

  4. Preventive Antibiotic Prophylaxis

Pharmacodynamics and Pharmacokinetics

  • Focus on how each medication used in dentistry follows pharmacodynamic and pharmacokinetic principles.

Definitions and Mechanisms

  • Pharmacodynamics:

    • Refers to what the drug does to the body.

    • Involves drug-receptor interactions, leading to a specific response.

  • Pharmacokinetics:

    • Refers to what the body does to the drug (absorption, distribution, metabolism, and excretion).

Drug-Receptor Interactions

  • Types of Interactions:

  1. Agonist: Activates the receptor for a physiological response.

  2. Antagonist: Blocks the agonist from binding—no effect if agonist is absent.

  3. Partial Agonist: Produces a weak response but can also inhibit the action of a full agonist.

Mechanism of Action Example

  • Epinephrine in Local Anesthetics:

    • Epi binds to vascular muscle receptors, resulting in vasoconstriction.

Pharmacokinetics Breakdown (ADME)

Absorption

  • Process of drug molecules entering circulation. Influenced by:

    • Route of administration

    • Vascularity of the area

    • Dosage form

Distribution

  • Movement from systemic circulation to target site. Affected by:

    • Plasma protein binding

    • Volume of distribution (Vd):

      • Vd = Q/C; a larger Vd indicates lower plasma concentration and more widespread distribution.

Metabolism

  • Primarily occurs in the liver and converts drugs into more polar, easily excreted forms.

  • Two Phases:

  1. Phase I: Oxidation-reduction reactions.

  2. Phase II: Conjugation/hydrolysis.

Excretion

  • Mainly through the kidneys; influenced by kidney function, blood flow, and molecular characteristics of the compounds.

Clinical Relevance

  • Understanding pharmacodynamics and pharmacokinetics essential for managing patient care and addressing their medication needs.

  • Important to evaluate drug interactions, especially in patients with complex medication regimens.

Pain Mechanism Overview

  • Pain is a primary motivation for dental visits; can be acute or chronic.

  • Two main components of pain:

    1. Perception: Physiological and neurologic interpretation.

    2. Reaction: Emotional response to pain, highly variable among individuals.

Nociception and Pain Fiber Types

  • Nociceptors: Respond to noxious stimuli; not all pain is nociceptive (e.g., neuropathic pain).

  • Nerve Fiber Types:

    • A Fibers: Fast, myelinated fibers, sharp pain.

    • C Fibers: Smaller, unmyelinated fibers, dull, aching pain.

Local Anesthetics Overview

  • Block pain sensory nerves before affecting motor nerves.

  • Two categories:

    1. Esters (topical use)

    2. Amides (injectable)

  • Pharmacokinetics: Involves ADME, influenced by various factors including vasodilation.

Summary and Clinical Practice Considerations

  • Local anesthetics must be understood regarding onset, duration, and factors impacting efficacy (e.g., pKa, lipid solubility, infection presence).

  • Importance of proper administration to ensure effective anesthesia, especially in the context of dental infections.

Conclusion

  • Mastery of pharmacodynamics and pharmacokinetics, pain pathways, and local anesthetic principles is critical for safe and effective dental practice.

Session Overview

Date: January 10, 2025Instructor: Patricia Greene, DMDMain Focus: Reinforce key points and practical knowledge on the application of pharmacology in dentistry.

Topics Covered:

  • Drug Action and Handling

    • Comprehensive understanding of Pharmacodynamics and Pharmacokinetics, which are crucial for safe medication administration in dental practices.

  • Pain Pathways

    • Insight into physiological and neurological aspects of pain, crucial for effective pain management strategies in dental care.

  • Pharmacology of Local Anesthetics

    • Detailed exploration of the different types of local anesthetics and their specific clinical applications.

Extra Focus:

  • Emphasis on clinical applications and relevance of these topics to enhance students' practical competencies in the dental field.

  • Stress on the importance of reading material to provide a solid theoretical foundation.

Pharmacology Course/Lectures:

  • Lecture sessions serve as a supplementary resource; students are required to engage with the provided modules/nodes for thorough understanding and context.

  • Structured opportunities will be given for students to ask questions, ensuring clarity and comprehension of complex material.

Lecture Engagement:

  • Students are encouraged to be active participants during the lecture; engagement will facilitate deeper learning.

  • Questions can be posed at any time via chat to promote an interactive and dynamic learning environment; active participation is emphasized as crucial for success.

  • Planned Breaks: Short breaks (5-10 minutes) will be integrated to enhance focus and retention throughout the session.

Application of Pharmacology in Dentistry:

  • Pain Management: Strategies for alleviating pain during and after dental procedures are discussed, highlighting the importance of effective medication use.

  • Infection Control: Overview of managing bacterial, viral, and fungal infections pertinent to dental care, with emphasis on using appropriate antibiotics and techniques to minimize cross-contamination.

  • Anxiety Management: Examination of pharmacological approaches to addressing dental anxiety to improve patient cooperation and comfort, including the use of sedatives and anti-anxiety medications.

  • Preventive Antibiotic Prophylaxis: Discussion on guidelines and pharmacological principles regarding the use of antibiotics to prevent infections in patients at risk, including criteria for prophylaxis in dental procedures (i.e., patients with prosthetic heart valves, certain orthopedic prostheses).

Pharmacodynamics and Pharmacokinetics:

  • Focus on how each medication used in dentistry adheres to pharmacodynamic and pharmacokinetic principles to ensure safety and effectiveness, detailing the implications of drug interactions and patient-specific factors.

Definitions and Mechanisms:

  • Pharmacodynamics:

    • Refers to the mechanisms of drug action, specifically, what the drug does to the body, involving interaction at the receptor level. These interactions lead to specific physiological responses or therapeutic effects, which are fundamental to effective patient care.

    • Examples: Investigate examples of drug actions such as the effect of NSAIDs in reducing inflammation through inhibition of cyclooxygenase enzymes and opioids in providing analgesia by binding to mu receptors in the central nervous system.

  • Pharmacokinetics:

    • Relates to the processes the body employs to manage drugs, including absorption, distribution, metabolism, and excretion (ADME). Proper understanding of pharmacokinetics helps determine optimal drug delivery systems for individual patients.

    • Clinical Application: Examine how factors like age, liver function, renal function, and obesity may affect drug metabolism and clearance, as well as dosing regimens adapted accordingly for specific populations (e.g., geriatric patients, children).

Drug-Receptor Interactions:

  • Types of Interactions:

    • Agonist: A substance that activates the receptor to produce a physiological response.

    • Antagonist: A substance that binds to the receptor but does not activate it, thereby blocking the action of an agonist and producing no effect if an agonist isn't present.

    • Partial Agonist: Produces a weaker response compared to full agonists and may inhibit the action of full agonists when they are present.

    • Example: Discuss the action of morphine as an agonist and naloxone as an antagonist in opioid management, as well as the clinical relevance of this knowledge in treating addiction and overdose cases.

Mechanism of Action Example:

  • Epinephrine in Local Anesthetics:

    • Epinephrine binds to vascular muscle receptors (alpha-1 adrenergic receptors), leading to vasoconstriction which helps to prolong the duration of action of local anesthetics during dental procedures and minimizes bleeding. Additionally, understanding the effect of epinephrine on heart rate and blood pressure is crucial as it influences patient care in high-risk individuals.

Pharmacokinetics Breakdown (ADME):

1. Absorption

  • The process through which drug molecules enter the bloodstream, influenced by factors such as:

    • Route of administration (oral, intravenous, topical, etc.)—e.g., intravenous administration leads to rapid effects, while oral administration may involve first-pass metabolism.

    • Vascularity of administration site: More vascular areas absorb drugs more effectively.

    • Dosage form (tablet, injection, etc.): Some forms dissolve faster than others (i.e., liquids vs. solids).

2. Distribution

  • Refers to the transit of drugs from systemic circulation to target sites. Factors affecting distribution include:

    • Plasma protein binding: Drugs that significantly bind to plasma proteins may have a limited free concentration in circulation, impacting their efficacy.

    • Volume of distribution (Vd): Calculated as Vd = Q/C, where Q is the dose and C is the plasma concentration. A larger Vd implies lower plasma concentration and more extensive distribution throughout tissues, affecting dosing strategies.

    • Blood-brain barrier: Some drugs, particularly those used for pain management, must penetrate the blood-brain barrier, which selective permeability limits.

3. Metabolism

  • Primarily occurs in the liver where drugs are converted to more polar forms for excretion. It involves:

    • Phase I: Involves oxidation-reduction reactions (e.g., CYP450 enzymes). These metabolic processes may activate drugs (prodrugs) or deactivate them—in which case knowing genetic polymorphisms affecting enzyme activity can be clinically significant.

    • Phase II: Involves conjugation and hydrolysis reactions that assist in preparing drugs for excretion, often producing inactive metabolites.

4. Excretion

  • The elimination of drugs and their metabolites from the body, mainly through the kidneys. Excretion processes are influenced by:

    • Renal function: Patients with impaired kidney function may require dose adjustments to prevent toxicity, emphasizing the need for renal function assessment (e.g., creatinine clearance).

    • Blood flow: Adequate renal blood flow is necessary for effective excretion.

    • Molecular characteristics: Drugs that are more hydrophilic are typically excreted more easily than lipophilic drugs, which may undergo reabsorption in renal tubules.

Clinical Relevance:

  • A thorough understanding of pharmacodynamics and pharmacokinetics is essential for managing patient care effectively and addressing diverse medication needs, ensuring patients receive appropriate therapeutic regimens tailored to their individual conditions.

  • It is crucial to evaluate drug interactions, especially in patients with complex medication regimens, to ensure safe and effective treatment outcomes. This includes:

    • Assessing contraindications and side effects of various medications used in a dental setting, which has a direct impact on patient safety and care quality.